NSEInitiation of Forensic Audit▼ NegativeRegulatory6 Aug 2026
Nath Bio-Genes (India) Limited
Initiation of Forensic Audit
Nath Bio-Genes (India) Limited has received a communication from SEBI to appoint a forensic auditor to conduct an audit of the company's books of account and records for the financial years 2020-21 to 2025-26.
NSEGeneral Updates▲ PositiveResults30 Jul 2026
Nath Bio-Genes (India) Limited
General Updates
Nath Bio-Genes (India) Limited has informed the Exchange about General Updates, including the presentation of unaudited financial results for the period ended 30th June 2026, with a 15% growth in revenue and a 12% growth in PAT.
NSEOutcome of Board MeetingResults29 Jul 2026
Nath Bio-Genes (India) Limited
Outcome of Board Meeting
Nath Bio-Genes (India) Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a net profit of Rs. 3265.68 lakhs and a basic earnings per share of Rs. 17.18.
NSECertificate under SEBI (Depositories and Participants) Regulations, 201823 Jul 2026
Nath Bio-Genes (India) Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Nath Bio-Genes (India) Limited has submitted a compliance certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities up to 30th June 2026.
NSETrading Window26 Jun 2026
Nath Bio-Genes (India) Limited
Trading Window
Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from July 1, 2026, to 48 hours after the declaration of Unaudited Financial Results for the quarter ending June 30, 2026.
NSEDisclosure under SEBI Takeover Regulations19 Jun 2026
Nath Bio-Genes (India) Limited
Disclosure under SEBI Takeover Regulations
Nath Bio-Genes (India) Limited has informed the exchanges about the submission of its annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing, made by the company's promoters for the financial year ended March 31, 2026, pertains to details of any shares encumbered (e.g., pledged). While the specific details of encumbrances are not provided in this announcement, it signifies the company's compliance with regulatory requirements concerning promoter shareholdings. Investors often monitor such disclosures for insights into promoter commitment and financial standing.